Literature DB >> 11960587

Prevention of heart failure.

Tamara B Horwich1, Gregg C Fonarow.   

Abstract

In light of the increasing prevalence, morbidity, and mortality of heart failure, preventative strategies are urgently needed. Risk factors include coronary artery disease, renal insufficiency, diabetes, and smoking. Essential strategies for prevention of heart failure are modification of risk factors for its development, and detection and treatment of asymptomatic left ventricular dysfunction (ALVD). In patients with ALVD, angiotensin-converting enzyme (ACE) inhibitor and beta-blocker therapy can prevent progression to symptomatic heart failure. Additional recently identified preventative strategies include ACE inhibitor therapy for all coronary artery disease and diabetic patients, clopidogrel therapy in acute coronary syndromes, and avoidance of calcium channel blockers and alpha-blockers as first-line antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960587     DOI: 10.1007/s11886-002-0050-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  38 in total

Review 1.  Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Authors:  R S McKelvie; C R Benedict; S Yusuf
Journal:  BMJ       Date:  1999-05-22

2.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Moderate alcohol consumption and risk of heart failure among older persons.

Authors:  J L Abramson; S A Williams; H M Krumholz; V Vaccarino
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

5.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

6.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

7.  Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.

Authors:  Y Sakata; T Masuyama; K Yamamoto; N Nishikawa; H Yamamoto; H Kondo; K Ono; K Otsu; T Kuzuya; T Miwa; H Takeda; E Miyamoto; M Hori
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

8.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

9.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

Review 10.  Asymptomatic left ventricular dysfunction in the community.

Authors:  T A McDonagh
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.